Sitemap
Pages
- AAGP® and Cell Doubling Time
- AAGP® bioactivity and potency assays
- AAGP® has an Additive Protective Effect on Oxidative Stress Induced Cell Death, in the Presence of Coenzyme Q10, in Human Adult and Neonatal Fibroblasts at 37°C
- AAGP® Increases Survival of Keratinocytes Under Normal Growth Conditions
- AAGP® Protects Human Adult Fibroblasts Against Oxidative Stress (Hydrogen Peroxide and UV) Induced Cell Death at 37°C
- AAGP® Protects Human Neonatal Skin Fibroblasts Against Low Temperature (-3°C and 3°C) Induced Cell Death
- AAGP® Protects Mouse Embryonic Stem Cells (E14K) During Cryopreservation
- AAGP® Reduces the Inflammatory Reaction (Cox-2 induction) in Response to an Inflammatory Stimulus (Interleukin-1β)
- AAGP® tested cell lines
- AAGP® Toxicity Data
- AAGP®’s Working Concentration Range
- AAGP®’s Working pH Range
- About
- An Investigation into the Ability of AAGP® to Protect Against UVA and UVC Stimulated Cell Death in Hela Cells and Adult Primary Fibroblasts
- Anti-Aging Glycopeptide (AAGP®)
- Applications
- Biomanufacturing
- Blog
- Cell Transplants
- Contact Us
- Corporate Policies and Disclosures
- Cosmetics
- Cryorecovery/Cell Product Collection, Handling and Installation
- Dermatological Inflammation
- Dermatology
- Diabetic Retinopathy
- Dose, toxicity and pH tests
- Dr. James Shapiro
- Dr. Kelly McNagny
- Dr. Kevin Gregory-Evans
- Dr. Thomas Pulinilkunnil
- Dry Eye Disease
- Effect of AAGP® on Maintaining Stem Cell Function in Mouse Neural Stem Cells During Cryopreservation
- Effect of AAGP® on Maintaining Stem Cell Number and Function in Mouse Neural Stem Cells During 4°C Refrigeration for Two Days
- Effect of AAGP® on Preservation of Blood Platelets at 22°C, 15°C and 4°C
- Effect of AAGP® on Preserving Cell Survival Number in Human and Mouse Neural Stem Cells During Cryopreservation
- Effect of AAGP® on the Functionality of Transplanted Islet Cells in a Diabetic Mouse Model
- Evaluation of AAGP® as a Protective Agent in the Cryopreservation (-196°C) of Processed Cord Blood
- For Investors
- For Media
- Home
- Investor FAQ Forum
- Investors and Media
- Is AAGP®’s Bioactivity pH Dependent?
- Lip Balm
- Login/Register
- Macular Degeneration
- Ophthalmology
- Press Releases
- Privacy Policy
- Protective Effects of Low Concentrations (1 and 5 mg/ml) of AAGP® on Oxidative Stress (Hydrogen Peroxide and UV) Induced Death in Human Adult and Neonatal Fibroblasts at 37°C
- ProtoKinetix Company Information
- ProtoKinetix Leadership Team
- Protokinetix Resources
- Research
- Research Partners
- Research Pipeline
- Retinal Graft Treatment for Blindness
- Sjogren’s Syndrome
- Sunburn treatment
- Terms of Use
- Transplants
- Type 1 Diabetes
- Uveitis
ProtoKinetix, Inc.